alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 15.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRMS

We consent to the incorporation by
reference in the Registration Statements (Form F-3 No. 333-118932 and Form S-8 No. 333-106591) of Deutsche Telekom AG and in the related Prospectuses of our reports dated March 1, 2007, with respect to the Deutsche Telekom
AGs consolidated financial statements, managements assessment of the effectiveness of internal control over financial reporting, and the effectiveness of internal control over financial reporting of the Company included in this Annual
Report (Form 20-F) for the year ended December 31, 2006.

March 1, 2007



|                                                                                            |  |                            
|------------------------------------------------------------------------------------------- |  | ---------------------------
|Ernst & Young AG Wirtschaftsprüfungsgesellschaft Steuerberatungsgesellschaft Stuttgart      |  |                            
|                                                                                            | 
|/s/ Prof. Dr. Pfitzer                                                                       |  | /s/ Hollweg                
|(Prof. Dr. Pfitzer) Wirtschaftsprüfer                                                       |  | (Hollweg) Wirtschaftsprüfer
|                                                                                            | 
|PricewaterhouseCoopers Aktiengesellschaft Wirtschaftsprüfungsgesellschaft Frankfurt am Main |  |                            
|                                                                                            | 
|/s/ Frings                                                                                  |  | /s/ Menke                  
|(Frings) Wirtschaftsprüfer                                                                  |  | (Menke) Wirtschaftsprüfer
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 7382 Introduced in House (IH)]

<DOC>

118th CONGRESS
  2d Session
                                H. R. 7382

  To amend the Omnibus Crime Control and Safe Streets Act of 1968 to 
  include an additional permissible use of amounts provided as grants 
          under the Byrne JAG program, and for other purposes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           February 15, 2024

    Mr. Luttrell (for himself, Mr. McCaul, Mrs. Wagner, Mrs. Chavez-
  DeRemer, Ms. Salazar, Mr. Bacon, Ms. Mace, Mrs. Miller-Meeks, Mrs. 
Gonzalez-Colon, Mr. Crenshaw, Mr. Stauber, Mr. Ellzey, and Mr. Deluzio) 
 introduced the following bill; which was referred to the Committee on 
                             the Judiciary

_______________________________________________________________________

                                 A BILL

 
  To amend the Omnibus Crime Control and Safe Streets Act of 1968 to 
  include an additional permissible use of amounts provided as grants 
          under the Byrne JAG program, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Empowering Law Enforcement To Fight 
Sex Trafficking Demand Act of 2024''.

SEC. 2. ADDITIONAL AUTHORIZED USE OF BYRNE JAG FUNDS.

    Section 501(a)(1) of the Omnibus Crime Control and Safe Streets Act 
of 1968 (34 U.S.C. 10152(a)(1)) is amended by adding at the end the 
following:
                    ``(I) Programs to combat human trafficking 
                (including programs to reduce the demand for trafficked 
                persons).''.
                                 <all>
```
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 7553 Introduced in House (IH)]

<DOC>

118th CONGRESS
  2d Session
                                H. R. 7553

 To provide that in order to be eligible for a grant under the Edward 
Byrne Memorial Justice Assistance Grant Program, a State shall provide 
 the Secretary of Homeland Security access to the State department of 
  motor vehicles records for the purpose of enforcing the immigration 
                                 laws.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             March 5, 2024

    Ms. Tenney (for herself, Mr. Langworthy, Mr. Garbarino, and Mr. 
Williams of New York) introduced the following bill; which was referred 
                   to the Committee on the Judiciary

_______________________________________________________________________

                                 A BILL

 
 To provide that in order to be eligible for a grant under the Edward 
Byrne Memorial Justice Assistance Grant Program, a State shall provide 
 the Secretary of Homeland Security access to the State department of 
  motor vehicles records for the purpose of enforcing the immigration 
                                 laws.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Ensuring States Support Law 
Enforcement Act''.

SEC. 2. BYRNE GRANTS CONDITIONED ON PROVIDING DMV RECORD ACCESS TO DHS.

    Beginning in the first fiscal year that begins after the date of 
enactment of this Act, in order to be eligible to receive a grant under 
the Edward Byrne Memorial Justice Assistance Grant Program under 
subpart I of part E of title I of the Omnibus Crime Control and Safe 
Streets Act of 1968 (34 U.S.C. 10151 et seq.), a State shall have in 
place a policy to provide the Secretary of Homeland Security access to 
the State department of motor vehicles records for the purpose of 
enforcing the immigration laws (as such term is defined in section 101 
of the Immigration and Nationality Act (8 U.S.C. 1101)).
                                 <all>
```
§ 529.1044b Gentamicin solution for dipping eggs. ( a ) *Specifications.* Each milliliter of solution contains gentamicin sulfate equivalent to 50 milligrams of gentamicin base.
( b ) *Sponsors.* See Nos. 000061 and 054925 in § 510.600(c) of this chapter.
( c ) *Conditions of use in turkeys* — ( 1 ) *Amount.* The drug is added to clean water to provide a dip solution with a gentamicin concentration of 250 to 1,000 parts per million. A concentration of 500 parts per million is recommended. Clean eggs should be held submerged in the gentamicin solution under a vacuum of about 27.5 to 38 centimeters of mercury for 5 minutes followed by additional soaking in gentamicin solution for approximately 10 minutes at atmospheric pressure. Eggs can also be treated by warming them for 3 to 6 hours at approximately 100 °F then immediately submerging them in gentamicin solution maintained at about 40 °F, keeping the eggs submerged for 10 to 15 minutes.
( 2 ) *Indications for use.* As an aid in the reduction or elimination of the following microorganisms from turkey-hatching eggs: *Arizona hinshawii* (*paracolon*), *Salmonella* Saintpaul, and *Mycoplasma meleagridis.*
( 3 ) *Limitations.* Eggs which have been dipped in the drug shall not be used for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[40 FR 13881, Mar. 27, 1975, as amended at 52 FR 7833, Mar. 13, 1987; 62 FR 22889, Apr. 28, 1997; 71 FR 13543, Mar. 16, 2006; 79 FR 10973, Feb. 27, 2014; 88 FR 16549, Mar. 20, 2023; 88 FR 55567, Aug. 16, 2023]
[Federal Register Volume 75, Number 40 (Tuesday, March 2, 2010)]
[Notices]
[Page 9415]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-4226]


-----------------------------------------------------------------------

FEDERAL RESERVE SYSTEM


Notice of Proposals to Engage in Permissible Nonbanking 
Activities or to Acquire Companies that are Engaged in Permissible 
Nonbanking Activities

    The companies listed in this notice have given notice under section 
4 of the Bank Holding Company Act (12 U.S.C. 1843) (BHC Act) and 
Regulation Y (12 CFR Part 225) to engage de novo, or to acquire or 
control voting securities or assets of a company, including the 
companies listed below, that engages either directly or through a 
subsidiary or other company, in a nonbanking activity that is listed in 
Sec. [thinsp]225.28 of Regulation Y (12 CFR 225.28) or that the Board 
has determined by Order to be closely related to banking and 
permissible for bank holding companies. Unless otherwise noted, these 
activities will be conducted throughout the United States.
    Each notice is available for inspection at the Federal Reserve Bank 
indicated. The notice also will be available for inspection at the 
offices of the Board of Governors. Interested persons may express their 
views in writing on the question whether the proposal complies with the 
standards of section 4 of the BHC Act. Additional information on all 
bank holding companies may be obtained from the National Information 
Center website at www.ffiec.gov/nic/.
    Unless otherwise noted, comments regarding the applications must be 
received at the Reserve Bank indicated or the offices of the Board of 
Governors not later than March 17, 2010.
    A. Federal Reserve Bank of Chicago (Colette A. Fried, Assistant 
Vice President) 230 South LaSalle Street, Chicago, Illinois 60690-1414:
    1. Northwest Financial Corp., Arnolds Park, Iowa; to engage de novo 
through its subsidiary, Northwest Wealth Management, LLC, Arnolds Park, 
Iowa, in investment advisory and transactional activities, pursuant to 
sections 225.28(b)(6)(i); (b)(6)(ii); b)(6)(v); (b)(7)(i); (b)(7)(ii) 
and (b)(9)(ii), all of Regulation Y.

    Board of Governors of the Federal Reserve System, February 25, 
2010.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. 2010-4226 Filed 3-1-10; 8:45 am]
BILLING CODE 6210-01-S
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 7468 Introduced in House (IH)]

<DOC>

118th CONGRESS
  2d Session
                                H. R. 7468

   To ensure that United States diplomats and officials of the U.S. 
Section of the International Boundary and Water Commission are able to 
 advance efforts seeking compliance by the United Mexican States with 
 the 1944 Treaty on Utilization of Waters of the Colorado and Tijuana 
                     Rivers and of the Rio Grande.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           February 28, 2024

Ms. De La Cruz (for herself, Mr. Cuellar, Mr. Weber of Texas, Mr. Self, 
   Mr. Crenshaw, Mr. Jackson of Texas, Mr. Nehls, Ms. Crockett, Mr. 
 Sessions, Mr. Carter of Texas, Ms. Van Duyne, Mr. Vicente Gonzalez of 
Texas, Mr. Pfluger, Mr. Hunt, Mr. Gooden of Texas, Mr. Tony Gonzales of 
 Texas, Mr. Moran, Mr. Arrington, Ms. Garcia of Texas, Mr. Babin, Mr. 
McCaul, Mr. Cloud, Mr. Fallon, Mr. Burgess, Mr. Williams of Texas, Mr. 
 Roy, Mr. Ellzey, Ms. Escobar, Mr. Castro of Texas, Mr. Luttrell, Mrs. 
 Fletcher, Mr. Veasey, and Ms. Granger) introduced the following bill; 
         which was referred to the Committee on Foreign Affairs

_______________________________________________________________________

                                 A BILL

 
   To ensure that United States diplomats and officials of the U.S. 
Section of the International Boundary and Water Commission are able to 
 advance efforts seeking compliance by the United Mexican States with 
 the 1944 Treaty on Utilization of Waters of the Colorado and Tijuana 
                     Rivers and of the Rio Grande.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. ADVANCING EFFORTS SEEKING COMPLIANCE BY MEXICO WITH TREATY 
              ON UTILIZATION OF WATERS OF THE COLORADO AND TIJUANA 
              RIVERS AND OF THE RIO GRANDE.

    The Secretary of State shall use the voice, vote, diplomatic 
capital, and resources of the United States to ensure that United 
States diplomats and officials of the U.S. Section of the International 
Boundary and Water Commission are able to advance efforts seeking 
compliance by the United Mexican States with the Treaty on Utilization 
of Waters of the Colorado and Tijuana Rivers and of the Rio Grande, 
signed at Washington February 3, 1944, and to establish understandings 
to provide predictable and reliable future deliveries of water by the 
United Mexican States.
                                 <all>
```
EXHIBIT 32
----------




                           CERTIFICATIONS OF
          CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
                  PURSUANT TO 18 U.S.C. SECTION 1350,
              AS ADOPTED PURSUANT TO SECTION 906 OF THE
                      SARBANES-OXLEY ACT OF 2002
          ---------------------------------------------------



     The following statement is provided by the undersigned to accompany
the Quarterly Report on Form 10-Q for the quarter ended September 30, 2004,
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be
deemed filed pursuant to any provision of the Securities Exchange Act of
1934 or any other securities law:

     Each of the undersigned certifies that the foregoing Report on
Form 10-Q fully complies with the requirements of Section 13(a) of the
Securities Exchange Act of 1934 (15 U.S.C. 78m) and that the information
contained in the Form 10-Q fairly presents, in all material respects, the
financial condition and results of operations of ARVIDA/JMB PARTNERS, L.P.




                                       /s/   Gary Nickele
                                       ------------------------------
                                       Gary Nickele
                                       Chief Executive Officer




                                       /s/   Gailen J. Hull
                                       ------------------------------
                                       Gailen J. Hull
                                       Chief Financial Officer and
                                       Principal Accounting Officer
#### § 558.630 Tylosin and sulfamethazine.

(a) *Specifications.* Type A medicated articles containing equal amounts of tylosin phosphate and sulfamethazine, available in concentrations of 5, 10, 20, or 40 grams each, per pound.

(b) *Sponsors.* See sponsor numbers in [§ 510.600(c) of this chapter](/on/2024-09-17/title-21/section-510.600#p-510.600(c)).

(1) No. 058198 for use as in [paragraph (e)(1)](/on/2024-09-17/title-21/section-558.630#p-558.630(e)(1)) of this section.

(2) No. 054771: 10 or 40 grams per pound each for use as in [paragraph (e)(2)](/on/2024-09-17/title-21/section-558.630#p-558.630(e)(2)) of this section.

(c) *Related tolerances.* See [§§ 556.670](/on/2024-09-17/title-21/section-556.670) and [556.746 of this chapter](/on/2024-09-17/title-21/section-556.746).

(d) *Special considerations.*

(1) Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian. See [§ 558.6](/on/2024-09-17/title-21/section-558.6) for additional requirements.

(2) The expiration date of VFDs for tylosin and sulfamethazine medicated feeds must not exceed 6 months from the date of issuance. VFDs for tylosin and sulfamethazine shall not be refilled.

(3) Labeling shall bear the statement: “Do not use in medicated feeds containing in excess of 2% bentonite.”

(e) *Conditions of use.* It is used in feed for swine as follows:

| Tylosin phosphate and sulfamethazine in grams/ton | Combination in grams/ton | Indications for use | Limitations | Sponsors |
| --- | --- | --- | --- | --- |
| (1) 100 each | | For reduction in the severity of effects of atrophic rhinitis; lowering the incidence and severity of *Bordetella bronchiseptica* rhinitis; prevention of swine dysentery associated with *Brachyspira hyodysenteriae;* control of swine pneumonias caused by bacterial pathogens (*Pasteurella multocida* and/or *Arcanobacterium pyogenes*); reducing the incidence of cervical lymphadenitis (jowl abscesses) caused by Group E *Streptococci.* Only the sulfamethazine portion of this combination is active in controlling jowl abscesses | Withdraw 15 days before swine are slaughtered | 058198 |
| (2) 100 each | | For reduction in the severity of effects of atrophic rhinitis; lowering the incidence and severity of *Bordetella bronchiseptica* rhinitis; prevention of swine dysentery associated with *Brachyspira hyodysenteriae;* and control of swine pneumonias caused by bacterial pathogens (*Pasteurella multocida* and/or *Arcanobacterium pyogenes*) | Withdraw 15 days before swine are slaughtered | 054771 |

[[81 FR 95021](https://www.federalregister.gov/citation/81-FR-95021), Dec. 27, 2016, as amended at [84 FR 33002](https://www.federalregister.gov/citation/84-FR-33002), July 11, 2019]
#### § 203.35 Standing requests.

Manufacturers or authorized distributors of record shall not distribute drug samples on the basis of open-ended or standing requests, but shall require separate written requests for each drug sample or group of samples. An arrangement by which a licensed practitioner requests in writing that a specified number of drug samples be delivered over a period of not more than 6 months, with the actual delivery dates for parts of the order to be set by subsequent oral communication or electronic transmission, is not considered to be a standing request.
§ 520.2220a Sulfadimethoxine oral solution and soluble powder. ( a ) *Specifications.* ( 1 ) Each ounce of solution contains 3.75 grams (12.5 percent) sulfadimethoxine.
( 2 ) Each 107 grams of powder contains the equivalent of 94.6 grams sulfadimethoxine as sulfadimethoxine sodium.
( b ) *Sponsors.* See sponsor numbers in § 510.600(c) of this chapter: ( 1 ) Nos. 016592, 054771, 054925, and 069043 for use of the product described in paragraph (a)(1) of this section.
( 2 ) Nos. 016592, 054771, 054925, 058829, 061133, and 066104 for use of the product described in paragraph (a)(2) of this section.
( c ) *Related tolerances.* See § 556.640 of this chapter.
( d ) *Conditions of use* — ( 1 ) *Broiler and replacement chickens* — ( i ) *Amount.* Administer 1.875 grams per gallon (0.05 percent) of drinking water for 6 consecutive days.
( ii ) *Indications for use.* For treatment of outbreaks of coccidiosis, fowl cholera, and infectious coryza.
( iii ) *Limitations.* Withdraw 5 days before slaughter. Do not administer to chickens over 16 weeks (112 days) of age. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
( 2 ) *Turkeys* — ( i ) *Amount.* Administer 0.938 grams per gallon (0.025 percent) of drinking water for 6 consecutive days.
( ii ) *Indications for use.* Growing turkeys: For treatment of disease outbreaks of coccidiosis and fowl cholera.
( iii ) *Limitations.* Withdraw 5 days before slaughter. Do not administer to turkeys over 24 weeks (168 days) of age. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
( 3 ) *Cattle* — ( i ) *Amount.* 1.18 to 2.36 grams per gallon (0.031 to 0.062 percent) of drinking water. As a drench, administer 2.5 grams per 100 pounds of body weight for first day, then 1.25 grams per 100 pounds of body weight per day for the next 4 consecutive days. If no improvement within 2 to 3 days, reevaluate diagnosis. Do not treat beyond 5 days.
( ii ) *Indications for use.* Dairy calves, dairy heifers, and beef cattle: For the treatment of shipping fever complex and bacterial pneumonia associated with *Pasteurella* spp. sensitive to sulfadimethoxine; and calf diphtheria and foot rot associated with *Fusobacterium necrophorum* (*Sphaerophorus necrophorus*) sensitive to sulfadimethoxine.
( iii ) *Limitations.* Withdraw 7 days before slaughter. A withdrawal period has not been established for this product in preruminating calves. Do not use in calves to be processed for veal. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Federal law prohibits the extralabel use of this product in lactating dairy cattle.
[79 FR 28829, May 20, 2014, as amended at 81 FR 22523, Apr. 18, 2016; 81 FR 94990, Dec. 27, 2016; 83 FR 48946, Sept. 28, 2018; 84 FR 8973, Mar. 13, 2019; 87 FR 10968, Feb. 28, 2022]
ARNOLD I. WATKINS

,

Appellant,

v.

STATE OF FLORIDA

,

Appellee

. IN THE DISTRICT COURT OF APPEAL FIRST DISTRICT, STATE OF FLORIDA

NOT FINAL UNTIL TIME EXPIRES TO
FILE MOTION FOR REHEARING AND
DISPOSITION THEREOF IF FILED

CASE NO. 1D 14

- 695

_____________________________/

Opinion filed February 4, 2015.

An appeal from the Circuit Court for Duval County

. James H. Daniel , Judge

.

Alvin E. Entin and Joseph E. Somake of Entin & Della Fera, P.A., Fort Lauderdale

, for Appellant.

Pamela Jo Bondi, Attorney General, and Kristen Lynn Bonjour, Assistant Attorney General, Tallahassee , for Appellee.

PER CURIAM.

AFFIRMED.

PADOVANO

, MARSTILLER

, and OSTERHAUS

, J J

. , CONCUR.
From: Chuck French [mailto:French.Chuck@epamail.epa.gov] 

Sent: Wednesday, May 23, 2012 10:24 AM

To: Marinshaw, Richard

Cc: Hancy, Cindy Wang; Phil Mulrine

Subject: RE: Review of impacted plants

I called and talked with the owner (Bill Onuska) of Hard Chrome Enterprises, Inc., in Lake Park, Florida. 

He was very helpful. They have a CMP as the main control device. They have 3 tanks, which are all 

ducted to the CMP. They also have in-line mist eliminators. They did compliance emissions tests in 1996 

on outlet of the CMP. The controls and operations have not changed since that time. The results for the 3 

runs were: 0.0036 mg/dscm, 0.00318 mg/dscm, and 0.00308 mg/dscm. He said he would fax results to 

me. He said the results we have in table 4 (i.e., 0.019 mg/dscm) are not correct.
§ 1314.15 Loss reporting. ( a ) Each regulated person must report to the Special Agent in Charge of the DEA Divisional Office for the area in which the regulated person making the report is located, any unusual or excessive loss or disappearance of a scheduled listed chemical product under the control of the regulated person. The regulated person responsible for reporting a loss in-transit is the supplier.
( b ) Each report submitted under paragraph (a) of this section must, whenever possible, be made orally to the DEA Divisional Office for the area in which the regulated person making the report is located at the earliest practicable opportunity after the regulated person becomes aware of the circumstances involved.
( c ) Written reports of losses must be filed within 15 days after the regulated person becomes aware of the circumstances of the event.
( d ) A report submitted under this section must include a description of the circumstances of the loss (in-transit, theft from premises, *etc.*).
( e ) A suggested format for the report is provided below:
Regulated Person Registration number (if applicable) Name Business address City State Zip Business phone Date of loss Type of loss Description of circumstances
§ 338.10 Nighttime sleep-aid active ingredients. The active ingredient of the product consists of any of the following when used within the dosage limits established for each ingredient in § 338.50(d): ( a ) Diphenhydramine hydrochloride.
( b ) Diphenhydramine citrate.